LUIZ FERNANDO CANEO

(Fonte: Lattes)
Índice h a partir de 2011
13
Lattes
ResearcherID
ORCID
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/11 - Laboratório de Cirurgia Cardiovascular e Fisiopatologia da Circulação, Hospital das Clínicas, Faculdade de Medicina
LIM/65, Hospital das Clínicas, Faculdade de Medicina - Líder

Filtros

Limpar filtros

Configurações

Colaboração internacional: Colômbia ×

Resultados de Busca

Agora exibindo 1 - 2 de 2
  • article 18 Citação(ões) na Scopus
    Development of an international standard set of patient-centred outcome measures for overall paediatric health: a consensus process
    (2021) ALGUREN, Beatrix; RAMIREZ, Jessily P.; SALT, Matthew; SILLETT, Nick; MYERS, Stacie N.; ALVAREZ-COTE, Albie; BUTCHER, Nancy J.; CANEO, Luiz F.; CESPEDES, Jaime A.; CHAPLIN, John E.; NG, Kee Chong; GARCIA-GARCIA, Juan J.; HAZELZET, Jan A.; KLASSEN, Anne F.; TURQUETTO, Aida Luiza R.; MEW, Emma J.; MORRIS, Michael; OFFRINGA, Martin; O'MEARA, Matthew; PAPP, James M.; RODRIGO, Carlos; SWITAJ, Timothy L.; MAYER, Catalina Valencia; JENKINS, Kathy J.
    Objective To develop an Overall Pediatric Health Standard Set (OPH-SS) of outcome measures that captures what matters to young people and their families and recognising the biopsychosocial aspects of health for all children and adolescents regardless of health condition. Design A modified Delphi process. Setting The International Consortium for Health Outcomes Measurement convened an international Working Group (WG) comprised of 23 international experts from 12 countries in the field of paediatrics, family medicine, psychometrics as well as patient advisors. The WG participated in 11 video-conferences, through a modified Delphi process and 9 surveys between March 2018 and January 2020 consensus was reached on a final recommended health outcome standard set. By a literature review conducted in March 2018, 1136 articles were screened for clinician and patient-reported or proxy-reported outcomes. Further, 4315 clinical trials and 12 paediatric health surveys were scanned. Between November 2019 and January 2020, the final standard set was endorsed by a patient validation (n=270) and a health professional (n=51) survey. Results From a total of 63 identified outcomes, consensus was formed on a standard set of outcome measures that comprises 10 patient-reported outcomes, 5 clinician-reported measures, and 6 case-mix variables. The four developmental age-specific packages (ie, 0-5, 6-12, 13-17, 18-24 years) include either five or six measures with an average time for completion of 20 min. Conclusions The OPH-SS is a starting point to drive value-based paediatric healthcare delivery from a global perspective for enhancing child and adolescent physical health and psychosocial well-being.
  • article 2 Citação(ões) na Scopus
    COVID-19 international experience in paediatric patients with congenital heart disease
    (2023) YEH, Mary J.; BERGERSEN, Lisa; GAUVREAU, Kimberlee; BARRY, Oliver M.; BATLIVALA, Sarosh P.; BJORNLUND, Elsa; BOE, Brian; CANEO, Luiz Fernando; CROTI, Ulisses A.; DOYLE, Thomas; FURNAZ, Shumaila; MORAES, Rodrigo Cesar; O'BYRNE, Michael L.; PAES, Erica de Oliveira; PALACIOS-MACEDO, Alexis; PECHILKOV, Dimitar; SANDOVAL, Nestor Fernando; SEN, Supratim; STAJEVIC, Mila; TRAVESSA, Marco Antonio Ferreira; JENKINS, Kathy J.
    ObjectiveAs COVID-19 continues to affect the global population, it is crucial to study the impact of the disease in vulnerable populations. This study of a diverse, international cohort aims to provide timely, experiential data on the course of disease in paediatric patients with congenital heart disease (CHD). MethodsData were collected by capitalising on two pre-existing CHD registries, the International Quality Improvement Collaborative for Congenital Heart Disease: Improving Care in Low- and Middle-Income Countries and the Congenital Cardiac Catheterization Project on Outcomes. 35 participating sites reported data for all patients under 18 years of age with diagnosed CHD and known COVID-19 illness during 2020 identified at their institution. Patients were classified as low, moderate or high risk for moderate or severe COVID-19 illness based on patient anatomy, physiology and genetic syndrome using current published guidelines. Association of risk factors with hospitalisation and intensive care unit (ICU) level care were assessed. ResultsThe study included 339 COVID-19 cases in paediatric patients with CHD from 35 sites worldwide. Of these cases, 84 patients (25%) required hospitalisation, and 40 (12%) required ICU care. Age <1 year, recent cardiac intervention, anatomical complexity, clinical cardiac status and overall risk were all significantly associated with need for hospitalisation and ICU admission. A multivariable model for ICU admission including clinical cardiac status and recent cardiac intervention produced a c-statistic of 0.86. ConclusionsThese observational data suggest risk factors for hospitalisation related to COVID-19 in paediatric CHD include age, lower functional cardiac status and recent cardiac interventions. There is a need for further data to identify factors relevant to the care of patients with CHD who contract COVID-19 illness.